Synendos Therapeutics
CHEntry
2021
Hold
5yr
Status
Active
Who owns Synendos Therapeutics?
Synendos Therapeutics is currently owned by Ysios Capital Partners through Ysios BioFund III (2020 vintage), since 2021. Across its history, Synendos Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Ysios Capital PartnersYsios BioFund III · 2020 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Ysios Capital PartnersActive
2021 · present(5yr) · Ysios BioFund III · 2020 · Life Sciences VC
More from Ysios BioFund III
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Synendos Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Synendos Therapeutics?
4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Synendos Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue